Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Le Xiong
Observed names:
Le XIONG,
Xiong, Le
Institutions:
Second Affiliated Hospital of Nanchang University,
Second Hospital of Nanchang
Observed institutions:
Qingdao University,
Nanchang University,
Key Laboratory of Guangdong Province,
Nanfang Hospital,
Second Affiliated Hospital of Nanchang University,
Second Hospital of Nanchang,
Southern Medical University,
South China University of Technology
show all 8
ORCID:
0009-0003-9768-0750
Observed ORCID:
0009-0003-9768-0750
OpenAlex ID:
A5109477695
Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients
2017
·
Le Xiong
, Xiao-Li Zeng
, et al.
·
BMC Cancer
·
41
PDF
USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway
2017
·
Jing Cai
, Tiande Liu
, et al.
·
Biochemical and Biophysical Research Communications
·
35
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo
2021
·
Le Xiong
, Xiao-Min Lin
, et al.
·
Nanotheranostics
·
33
PDF
Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
2022
·
Yali Yi
, Jing Cai
, et al.
·
Journal of Translational Medicine
·
30
PDF
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
2021
·
Xiao-Min Lin
, Xiao-Xiao Shi
, et al.
·
International Journal of Molecular Sciences
·
28
PDF
BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest
2020
·
Zhi-min Zeng
, Hai-yang Du
, et al.
·
Life Sciences
·
27
Clinicopathologic characteristics and prognostic factors for primary spinal epidural lymphoma: report on 36 Chinese patients and review of the literature
2017
·
Le Xiong
, Ling-Min Liao
, et al.
·
BMC Cancer
·
24
PDF
Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast
2023
·
Peng Xu
, Yali Yi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
23
PDF
Biological implications of PTEN upregulation and altered sodium/iodide symporter intracellular distribution in resveratrol-suppressed anaplastic thyroid cancer cells
2020
·
Le Xiong
, Jun-Hua Nie
, et al.
·
Journal of Cancer
·
18
PDF
Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment
2025
·
Yali Yi
, Wenjie Xu
, et al.
·
Journal of Translational Medicine
·
16
PDF
Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling Pathway
2022
·
Hanjie Yi
, Yongqing Han
, et al.
·
Journal of Oncology
·
15
PDF
High Expression of IL-4R Enhances Proliferation and Invasion of Hepatocellular Carcinoma Cells
2017
·
Changkuo Guo
, Yuming Ouyang
, et al.
·
The International Journal of Biological Markers
·
15
Differential Exosomic Proteomic Patterns and Their Influence in Resveratrol Sensitivities of Glioblastoma Cells
2019
·
Jun-Hua Nie
, Hong Li
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors
2023
·
Zhiqin Lu
, Yali Yi
, et al.
·
Translational Oncology
·
9
Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
2022
·
Ruxia Deng
, Xiansheng Lu
, et al.
·
Journal of Translational Medicine
·
8
PDF
Novel antagonist APG-115 targets MDM2-p53 to induce p53-mediated apoptosis and radiosensitization in colorectal cancer
2026
·
HanJie Yi
, YongQing Han
, et al.
·
Clinical and Experimental Medicine
·
3
PDF
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
·
Clinical Cancer Research
·
2
Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings
2024
·
Duanyang Peng
, Le Xiong
, et al.
·
Journal of Cancer Research and Therapeutics
·
2
Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
2022
·
Yali Yi
, Jing Cai
, et al.
·
Journal of Translational Medicine
·
2
PDF
Comparative analysis of PD-L1 expression and tumor-infiltrating lymphocytes between primary breast cancer and matched metastatic lesions: implications for immunotherapy
2025
·
Daolin Zeng
, Qin Li
, et al.
·
Central European Journal of Immunology
·
1
PDF
IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA
2026
·
HanJie Yi
, YongQing Han
, et al.
·
Medical Oncology
The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasis
2026
·
Hanjie Yi
, Shanfeng Li
, et al.
·
Translational Oncology
Figure S1,S2 and Table S1, S2 from The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
Data from The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
Breaking Down Combination Strategies: PD-1/PD-L1 Inhibitors with Chemotherapy, Anti- Angiogenesis, or Both in Driver Gene-Negative NSCLC Clinical Outcomes and Mechanistic Insights
2025
·
Yali Yi
, Zhiqin Lu
, et al.
·
Research Square
Show more works
View as search
Works count:
31
Citation count:
343
H-index:
12
I10-index:
13
Year
Topic
Type